| __timestamp | BioMarin Pharmaceutical Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 293000 |
| Thursday, January 1, 2015 | 634806000 | 1002000 |
| Friday, January 1, 2016 | 661905000 | 888000 |
| Sunday, January 1, 2017 | 610753000 | 19623000 |
| Monday, January 1, 2018 | 696328000 | 30421000 |
| Tuesday, January 1, 2019 | 715007000 | 34794000 |
| Wednesday, January 1, 2020 | 628116000 | 28304000 |
| Friday, January 1, 2021 | 628793000 | 56886000 |
| Saturday, January 1, 2022 | 649606000 | 100894000 |
| Sunday, January 1, 2023 | 746773000 | 159765000 |
| Monday, January 1, 2024 | 747184000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, BioMarin Pharmaceutical Inc. and Viridian Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. BioMarin, a leader in the field, has consistently allocated substantial resources, with a peak in 2023 where their R&D expenses surged by approximately 62% compared to 2014. This commitment underscores their dedication to pioneering treatments.
In contrast, Viridian Therapeutics, Inc. has shown a remarkable growth trajectory in R&D spending, increasing from a modest base in 2014 to a significant rise by 2023, marking an impressive 54,000% increase. This dramatic escalation highlights Viridian's strategic pivot towards innovation.
These trends reflect broader industry dynamics, where established players and emerging companies alike are investing heavily in R&D to drive future breakthroughs.
Analyzing R&D Budgets: AbbVie Inc. vs BioMarin Pharmaceutical Inc.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
R&D Spending Showdown: argenx SE vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Research and Development Investment: Insmed Incorporated vs BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Axsome Therapeutics, Inc.
Research and Development: Comparing Key Metrics for BioMarin Pharmaceutical Inc. and PTC Therapeutics, Inc.
Viking Therapeutics, Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: ImmunityBio, Inc. vs Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Viridian Therapeutics, Inc. vs MiMedx Group, Inc.